Association of plasma markers of cholesterol homeostasis with metabolic syndrome components. A cross-sectional study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 9, 2011, Pages 651-657

  Cofan M ^a,b   Escurriol, V ^a,b   Garcia Otin A L ^c   Moreno Iribas, C ^d,e,f   Larranaga N ^e,g   Sanchez M J ^e,h   Tormo, M J ^e,i   Redondo, M L ^j   Gonzalez C A ^e,k   Corella, D ^b,l   Pocovi M ^m,n   Civeira, F ^c,e   Ros, E ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g Public Health Department of Gipuzkoa   (Spain)

^h ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

ⁱ DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^j Health and Health Care Services Council   (Spain)

^k CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^l UNIVERSITY OF VALENCIA   (Spain)

^m UNIVERSITY OF ZARAGOZA   (Spain)

ⁿ CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

more..

Author keywords

Adiposity; Cardiovascular risk factors; Cholesterol metabolism; Lathosterol; Lipids and lipoproteins; Metabolic syndrome; Phytosterols

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; CHOLESTEROL; LATHOSTEROL; PHYTOSTEROL; SITOSTEROL; SITOSTEROL DERIVATIVE;

ADULT; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HOMEOSTASIS; HUMAN; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HOMEOSTASIS; HUMANS; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; PHYTOSTEROLS; PROSPECTIVE STUDIES; RISK FACTORS; SITOSTEROLS;

EID: 80052722000     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.01.005     Document Type: Article

References (28)

1. Moreau R.A., Whitaker B.D., Hicks K.B. Phytosterols, phytostanols, and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses. Progr Lipid Res 2002, 41:457-500.
2. von Bergmann K., Sudhop T., Lütjohann D. Cholesterol and plant sterol absorption: recent insights. Am J Cardiol 2005, 96(Suppl.):10D-14D.
3. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000, 290:1771-1775.
4. Chan Y.M., Varady K.A., Lin Y., Trautwein E., Mensink R.P., Plat J., et al. Plasma concentrations of plant sterols: physiology and relationship with coronary heart disease. Nutr Rev 2006, 64:385-402.
5. Katan M.B., Grundy S.M., Jones P., Law M., Miettinen T., Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003, 78:965-978.
6. Miettinen T.A., Tilvis R.S., Kesäniemi Y.A. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990, 131:20-31.
7. Santosa S., Varady K.A., AbuMweis S., Jones P.J. Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist?. Life Sci 2007, 80:505-514.
8. Miettinen T.A. Cholesterol production in obesity. Circulation 1971, 44:842-847.
9. Miettinen T.A., Gylling H. Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis 2000, 153:241-248.
10. Simonen P., Gylling H., Howard A.N., Miettinen T.A. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 2000, 72:82-88.
11. Simonen P.P., Gylling H.K., Miettinen T.A. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 2002, 25:1511-1515.
12. Pihlajamäki J., Gylling H., Miettinen T.A., Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004, 45:507-512.
13. Chan D.C., Watts G.F., Barrett P.H., O'Neill F.H., Redgrave T.G., Thompson G.R. Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome. Clin Sci (Lond) 2003, 104:383-388.
14. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. [erratum in Circulation 2005;112:e297-98].
15. Bingham S., Riboli E. Diet and cancer. The European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 2004, 4:206-215.
16. Durrington P. Dyslipidaemia. Lancet 2003, 362:717-731.
17. González C.A. EPIC Group of Spain. Relative validity and reproducibility of a diet history questionnaire in Spain. I. Foods. Int J Epidemiol 1997, 26(Suppl. 1):S91-S99.
18. Jiménez-Escrig A., Santos-Hidalgo A.B., Saura-Calixto F. Common sources and estimated intake of plant sterols in the Spanish diet. J Agric Food Chem 2006, 54:3462-3471.
19. Heinemann T., Axtmann G., von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 1993, 23:827-831.
20. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990, 31:345-348.
21. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005, 366:1059-1062.
22. Miettinen T.A., Gylling H. Cholesterol synthesis and absorption in coronary patients with lipid triad and isolated high LDL cholesterol in a 4S subgroup. Atherosclerosis 2003, 168:343-349.
23. Gylling H., Hallikainen M., Pihlajamäki J., Agren J., Laakso M., Rajaratnam R.A., et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res 2004, 45:1660-1665.
24. Pinedo S., Vissers M.N., von Bergmann K., Elharchaoui K., Lütjohann D., Luben R., et al. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk Population Study. J Lipid Res 2007, 48:139-144.
25. Assmann G., Cullen P., Kannenberg F., Schulte H. Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM study. Eur J Cardiovasc Prev Rehabil 2007, 14:208-214.
26. Ory D.S. Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?. Circ Res 2004, 95:660-670.
27. Yu L., York J., von Bergmann K., Lutjohann D., Cohen J.C., Hobbs H.H. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 2003, 278:15565-15570.
28. Field F.J., Watt K., Mathur S.N. Origins of intestinal ABCA1-mediated HDL-cholesterol. J Lipid Res 2008, 49:2605-2619.